|
BRIX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.781699999992E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.390600E-04 |
| Normal-vs-Stage2 |
8.003900E-03 |
| Normal-vs-Stage3 |
1.202640E-03 |
| Normal-vs-Stage4 |
1.629820E-04 |
| Stage1-vs-Stage2 |
8.169800E-01 |
| Stage1-vs-Stage3 |
9.385600E-01 |
| Stage1-vs-Stage4 |
1.775240E-01 |
| Stage2-vs-Stage3 |
8.889200E-01 |
| Stage2-vs-Stage4 |
4.151200E-01 |
| Stage3-vs-Stage4 |
2.416200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53551999999557E-05 |
| Normal-vs-AfricanAmerican |
6.322200E-02 |
| Normal-vs-Asian |
3.322200E-01 |
| Caucasian-vs-AfricanAmerican |
1.686970E-01 |
| Caucasian-vs-Asian |
9.490800E-01 |
| AfricanAmerican-vs-Asian |
5.515200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.42909999999386E-05 |
| Normal-vs-Female |
3.88540000000326E-05 |
| Male-vs-Female |
4.899200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.827560E-01 |
| Normal-vs-Age(41-60Yrs) |
2.303000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.79629999985664E-07 |
| Normal-vs-Age(81-100Yrs) |
7.396100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.659200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.065600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.051400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.823500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.476400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.815000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.179220E-01 |
| Normal-vs-Grade 2 |
4.82869999995916E-06 |
| Normal-vs-Grade 3 |
5.577200E-03 |
| Normal-vs-Grade 4 |
2.103000E-03 |
| Grade 1-vs-Grade 2 |
4.712800E-01 |
| Grade 1-vs-Grade 3 |
9.273600E-01 |
| Grade 1-vs-Grade 4 |
5.956800E-01 |
| Grade 2-vs-Grade 3 |
2.011800E-02 |
| Grade 2-vs-Grade 4 |
9.312800E-01 |
| Grade 3-vs-Grade 4 |
1.861440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24300000017941E-07 |
| Normal-vs-ccB subtype |
8.341100E-03 |
| ccA subtype-vs-ccB subtype |
7.438400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.210500E-04 |
| Normal-vs-N1 |
7.707900E-02 |
| N0-vs-N1 |
4.406800E-01 |
|
|
